Next-Gen Patient Avatar
Features histopathology and molecular pathology indistinguishable from patient tumors.Predicts patient responses validated by a prospective clinical study.Fully compatible with drug R&D and personalized therapies (chemo, radio, immunetherapy, targeted and combo).

Generative AI Model
Predicts patient responses to drug treatments.Provides FIC drug targets for aiPTO-based pipeline development.Predicts and identify solutions overcome drug resistance.